Home/ Supplements/ Omega 3/ Heart Heath Omega-3 Fish Oil

Heart Heath Omega-3 Fish Oil

product on market Softgel Capsule Life Extension Safety: 96/100
96/100

This product looks safe

  • Fish Oil Concentrate: 3182mg is 1.1× the Tolerable Upper Intake Level (3000mg)
  • 56% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Vitamin D3 and K2 are supported by moderate to strong evidence for supporting bone density and cardiovascular health. These ingredients work synergistically to regulate calcium absorption and distribution in the body. The product maintains a high safety profile for general consumption.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Fish Oil Concentrate: 3182mg is 1.1× the Tolerable Upper Intake Level (3000mg)

Label

Product Label

Label for Heart Heath Omega-3 Fish Oil
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Softgel(s)
Serving Size
30
Servings
Other Combinations
Product Type
56%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
30 {Calories}
Total Fat
3 Gram(s) (5% DV)
Cholesterol
5 mg (2% DV)
2000 IU (500% DV)
3.3× RDA — above typical dose (UL: 0.1 mg) 608 studies (A:16, B:251)
100 mcg (125% DV)
Within RDA (0.8× RDA) 275 studies (A:9, B:175)
Exceeds UL by 1.1× (UL: 3000 mg) 393 studies (A:18, B:204)
Market median: 200.0mg (198 products) 6 studies — no high-quality reviews
100 mg
Market median: 100.0mg (283 products) 144 studies (A:1, B:64)
Market median: 200.0mg (52 products) 12 studies (A:0, B:6)

Other Ingredients

highly refined Fish Oil concentrate Gelatin Beeswax Glycerin purified Water Olive Oil Caramel color Mixed Tocopherols
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Read the entire label and follow the directions carefully prior to use. DIRECTIONS: Take three (3) softgels daily with food, or as recommended by a healthcare practitioner.

Warnings & Precautions

WARNINGS: -Keep out of reach of children.

-DO NOT EXCEED RECOMMENDED DOSE. -Do not purchase if outer seal is broken or damaged.

-When using nutritional supplements, please consult with your physician if you are undergoing treatment for a medical condition or if you are pregnant or lactating.

CAUTION: If you are taking anti-coagulant or anti-platelet medications, or have a bleeding disorder, consult your healthcare provider before taking this product. Individuals consuming more than 2,000 IU/day of vitamin D (from diet and supplements) should periodically obtain a serum 25-hydroxy vitamin D measurement. Do not exceed 10,000 IU per day unless recommended by your doctor. Vitamin D supplementation is not recommended for individuals with high blood calcium levels. If you are taking glucose lowering medication, consult your healthcare provider before taking this product.

Formulation Notes

with CoQ10 -Lipoic Acid Vitamins D3 and K2

Additional Information

Store tightly closed in a cool, dry place.

Scan for product info

Q01262A

Kaneka Q10

Metadata

Product Details

UPC / SKU7 37870 12629 4
DSLD Entry Date2016-04-22
Product TypeOther Combinations
FormSoftgel Capsule
DSLD ID59028
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.